Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lasa Supergenerics is a vertically integrated pharmaceutical company based in India, specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs). The company holds a dominant market position in the production of anthelmintic drugs, including Albendazole and Fenbendazole, serving both the human and veterinary healthcare sectors. Lasa operates multiple manufacturing units in Maharashtra, which are equipped with advanced technologies for complex chemical synthesis. Their business model focuses on cost-effective production and global distribution of high-quality generic APIs and animal feed supplements. The company is recognized for its ability to manufacture key starting materials internally, ensuring supply chain resilience and competitive pricing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LASA Laboratory.